The Federal Trade Commission has challenged the validity of over 100 drug product patents, focusing on devices used to deliver medicines, like inhalers and autoinjectors, in an effort to increase competition and potentially lower some prices.
Investigative report reveals growing delays in complaint processing times against drug companies
Processing times for complaints against drug companies suspected of having breached their industry code of practice have more than tripled in a nearly two-decade period,
February 16, 2024